Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Dec. 31, 2021	Sep. 30, 2021
Current Assets:
Cash and cash equivalents	$ 65,421,424	$ 70,072,946
Prepaid expenses	2,523,552	2,741,404
Total Current Assets	67,944,976	72,814,350
Property and equipment, net	6,293	7,023
Operating lease right-of-use asset, net	779,949	822,828
Other Assets:
Deposits	38,062	38,062
In-process research and development	59,400,000	59,400,000
Goodwill	9,346,796	9,346,796
Total Other Assets	68,784,858	68,784,858
Total Assets	137,516,076	142,429,059
Current Liabilities:
Accounts payable	1,789,203	1,277,095
Accrued expenses	3,136,609	621,960
Accrued compensation	2,233,690	1,906,000
Operating lease liability	182,028	177,237
Total Current Liabilities	7,341,530	3,982,292
Deferred tax liability	4,985,800	4,985,800
Operating lease liability – non current	630,745	678,234
Total Liabilities	12,958,075	9,646,326
Commitments and Contingencies
Stockholders’ Equity:
Preferred stock – $0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding
Common stock – $0.001 par value; 400,000,000 shares authorized; 146,029,630 and 145,979,429 shares issued and outstanding at December 31, 2021 and September 30, 2021, respectively	146,029	145,979
Additional paid-in capital	229,084,633	228,084,195
Accumulated deficit	(105,273,041)	(96,047,821)
Total Citius Pharmaceuticals, Inc. Stockholders’ Equity	123,957,621	132,182,353
Non-controlling interest	600,380	600,380
Total Equity	124,558,001	132,782,733
Total Liabilities and Equity	$ 137,516,076	$ 142,429,059

Amount of in process research and development.

No definition available.

Name:	ctxr_InProcessResearchAndDevelopment
Namespace Prefix:	ctxr_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).